\-\ Texto\\:\\ \ \(0\)\
\-\ mass\\ in\\ nose\\ and\\ throat\\.\ \(0\)\
\-\ radiation\\ therapy\\ and\\ chemotherapy\ \(5\)\
\-\ infiltrative\\ and\\ destructive\\ central\\ skull\\ base\\ mass\\ with\\ both\\ intra\\ and\\ extracranial\\ extension\\.\\ \\ mass\\ is\\ lobulated\\,\\ destroys\\ bone\\,\\ and\\ enhances\\ following\\ contrast\\ administration\\.\ \(0\)\
\-\ plasmacytoma\ \(10\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ \\â\\€\\¢\\ nasopharyngeal\\ carcinoma\ \(0\)\
\-\ \\â\\€\\¢\\ chordoma\ \(1\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ chloroma\\,\\ plasmacytoma\ \(0\)\
\-\ 64\\ year\\ old\\ man\\ presents\\ with\\ nasal\\ congestion\\,\\ bilateral\\ hearing\\ loss\\ and\\ mass\\ in\\ throat\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ plasmacytoma\\:\\ 0\\.37593876865635006\ \(0\)\
\-\ throat\\:\\ 0\\.3176518950907871\ \(0\)\
\-\ destroys\\:\\ 0\\.24198854442260287\ \(0\)\
\-\ mass\\:\\ 0\\.2419497996746606\ \(0\)\
\-\ chloroma\\:\\ 0\\.22274653135542882\ \(0\)\
\-\ extracranial\\:\\ 0\\.21846725347803242\ \(0\)\
\-\ and\\:\\ 0\\.19633295035634485\ \(0\)\
\-\ nasopharyngeal\\:\\ 0\\.19074773685037055\ \(0\)\
\-\ chordoma\\:\\ 0\\.18099280612288815\ \(0\)\
\-\ destructive\\:\\ 0\\.16872737126100099\ \(0\)\
\-\ infiltrative\\:\\ 0\\.16226969333802158\ \(0\)\
\-\ nose\\:\\ 0\\.1602498677005132\ \(0\)\
\-\ congestion\\:\\ 0\\.15660393341883824\ \(0\)\
\-\ 64\\:\\ 0\\.14883214318936236\ \(0\)\
\-\ lobulated\\:\\ 0\\.14606916610750934\ \(0\)\
\-\ nasal\\:\\ 0\\.14436902121734183\ \(0\)\
\-\ hearing\\:\\ 0\\.1438246830547345\ \(0\)\
\-\ enhances\\:\\ 0\\.13958393447821948\ \(0\)\
\-\ intra\\:\\ 0\\.13265881200004437\ \(0\)\
\-\ skull\\:\\ 0\\.12848273259401802\ \(0\)\
\-\ administration\\:\\ 0\\.12610606426898086\ \(0\)\
\-\ base\\:\\ 0\\.12045783121129286\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.11244265137331828\ \(0\)\
\-\ extension\\:\\ 0\\.11209672344744312\ \(0\)\
\-\ central\\:\\ 0\\.10574790662253035\ \(0\)\
\-\ radiation\\:\\ 0\\.1049392953723825\ \(0\)\
\-\ loss\\:\\ 0\\.09647577687860294\ \(0\)\
\-\ following\\:\\ 0\\.0949980528259049\ \(0\)\
\-\ carcinoma\\:\\ 0\\.0947209088585243\ \(0\)\
\-\ lymphoma\\:\\ 0\\.09431031269384524\ \(0\)\
\-\ therapy\\:\\ 0\\.09098531906852252\ \(0\)\
\-\ both\\:\\ 0\\.08830662413040716\ \(0\)\
\-\ metastatic\\:\\ 0\\.08684989246559617\ \(0\)\
\-\ bone\\:\\ 0\\.08640351965877474\ \(0\)\
\-\ bilateral\\:\\ 0\\.08510591506349618\ \(0\)\
\-\ man\\:\\ 0\\.08383519635056427\ \(0\)\
\-\ in\\:\\ 0\\.0787872570419287\ \(0\)\
\-\ contrast\\:\\ 0\\.07694154683078351\ \(0\)\
\-\ presents\\:\\ 0\\.07617701364138672\ \(0\)\
\-\ disease\\:\\ 0\\.06647187728927981\ \(0\)\
\-\ with\\:\\ 0\\.06201584640076959\ \(0\)\
\-\ year\\:\\ 0\\.04880194750757192\ \(0\)\
\-\ old\\:\\ 0\\.046866762820630486\ \(0\)\
\-\ is\\:\\ 0\\.04336664082390483\ \(0\)\
